What data powers the Rallies AI report for IBB?

Rallies AI research for IBB combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.

Is IBB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.

IBB (Nasdaq Biotechnology) Stock Analysis - AI Report

Nasdaq Biotechnology (IBB) is a publicly traded the market company. As of May 20, 2026, IBB trades at $167.11 with a market cap of $0 and a P/E ratio of 0.00. IBB moved +2.20% today. Year to date, IBB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on IBB?

Rallies AI research for IBB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

IBB Key Metrics

Key financial metrics for IBB
Metric	Value
Price	$167.11
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$0.00
52-Week Low	$0.00
Volume	1.77M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest IBB News

IBB flat as biotech earnings setup and M&A optimism offset rate sensitivity — May 7, 2026
IBB holds near $170 as biotech balances rates, M&A buzz, and mixed catalysts — May 6, 2026
IBB holds steady as biotech digests big-pharma earnings and rate sensitivity — May 5, 2026
IBB holds steady as large-cap biotech earnings and rate outlook offset catalyst calendar — May 4, 2026
IBB flat as biotech digests mega-cap earnings and May FDA catalyst calendar — May 1, 2026

IBB Analyst Consensus

IBB analyst coverage data. Average price target: $0.00.

Common questions about IBB

What is the AI research view on IBB?: Rallies AI research for IBB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for IBB?: Rallies AI research for IBB combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is IBB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.